Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
04.06.Turning cold facts into compassionate conversations: the power of patient-centricity in medical education
03.06.BMS and BioNTech partner on solid tumour candidate in deal worth over $11bn
03.06.AstraZeneca's Forxiga recommended by NICE for wider chronic kidney disease use
03.06.Roche/Jazz Pharmaceuticals share positive phase 3 results for lung cancer combination therapy
03.06.Focusing on the patient voice to improve outcomes
03.06.How can we achieve the right balance of HCP engagements in medcomms?
02.06.Pfizer shares 'unprecedented' survival results for Braftovi in colorectal cancer
02.06.Sanofi to expand immunology capabilities with $9.5bn Blueprint Medicines acquisition
02.06.Eli Lilly's Omvoh recommended by NICE to treat Crohn's disease in adults
02.06.Between luck and leadership: success because of, not despite, strategy
02.06.The evolution of AI in clinical trials: from promise to practice
30.05.Roche shares positive 96-week results for multiple sclerosis candidate fenebrutinib
30.05.AstraZeneca receives CHMP recommendation for Imfinzi regimen in bladder cancer
30.05.Sanofi and Stagecoach Performing Arts partner to highlight impact of autoimmune type 1 diabetes
30.05.UKDRI researchers to evaluate new blood test for neurodegenerative disease diagnosis
30.05.In an era of deep uncertainty, life sciences companies require more than agile communications
30.05.Can we create a world where health is sustainable?
29.05.Biogen and City Therapeutics to develop RNAi therapies in deal worth over $1bn
29.05.Sanofi gains access to Alzheimer's candidate through $470m Vigil acquisition
29.05.The future of customer engagement in biopharma
28.05.J&J's Darzalex Faspro recommended by FDA panel of experts for smouldering multiple myeloma
28.05.Merck shares promising phase 3 results for Keytruda in ovarian cancer
28.05.Improving engagement with clinical trials: time to apply behavioural science
27.05.Bristol Myers Squibb's perioperative Opdivo regimen granted EC approval in NSCLC
27.05.Boehringer's nerandomilast shows lung function benefit in phase 3 IPF and PPF trials